Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy - PubMed
- ️Sun Jan 01 2017
Review
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy
Uday C Ghoshal et al. Gut Liver. 2017.
Abstract
The pathogenesis of irritable bowel syndrome (IBS), once thought to be largely psychogenic in origin, is now understood to be multifactorial. One of the reasons for this paradigm shift is the realization that gut dysbiosis, including small intestinal bacterial overgrowth (SIBO), causes IBS symptoms. Between 4% and 78% of patients with IBS and 1% and 40% of controls have SIBO; such wide variations in prevalence might result from population differences, IBS diagnostic criteria, and, most importantly, methods to diagnose SIBO. Although quantitative jejunal aspirate culture is considered the gold standard for the diagnosis of SIBO, noninvasive hydrogen breath tests have been popular. Although the glucose hydrogen breath test is highly specific, its sensitivity is low; in contrast, the early-peak criteria in the lactulose hydrogen breath test are highly nonspecific. Female gender, older age, diarrhea-predominant IBS, bloating and flatulence, proton pump inhibitor and narcotic intake, and low hemoglobin are associated with SIBO among IBS patients. Several therapeutic trials targeting gut microbes using antibiotics and probiotics have further demonstrated that not all symptoms in patients with IBS originate in the brain but rather in the gut, providing support for the micro-organic basis of IBS. A recent proof-of-concept study showing the high frequency of symptom improvement in patients with IBS with SIBO further supports this hypothesis.
Keywords: Bacterial overgrowth; Breath tests; Dysbiosis; Gastrointestinal microbiota; Probiotics; Rifaximin.
Conflict of interest statement
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was reported.
Figures

Schematic diagram showing the frequency of small intestinal bacterial overgrowth (SIBO) using quantitative jejunal aspirate culture, glucose and lactulose hydrogen breath tests (GHBT and LHBT, respectively) among patients with irritable bowel syndrome (IBS), gut defense mechanisms that prevent the development of SIBO, factors associated with SIBO among patients with IBS, and mechanisms of IBS symptom development. As shown in the figure, the frequency of SIBO in IBS patients using LHBT (early-peak criteria) is higher than that by using upper gut aspirate culture and GHBT (LHBT [45%]; upper gut aspirate culture [23%] and GHBT [26%]). Moreover, SIBO is more frequent in healthy controls using LHBT due to false positive test results (LHBT [21%], upper gut aspirate culture [1%] and GHBT [5%]). GI, gastrointestinal; IBS-D, irritable bowel syndrome, diarrhea-predominan; PPI, proton pump inhibitor; CHO, carbohydrate.
Similar articles
-
Ghoshal UC, Srivastava D, Ghoshal U, Misra A. Ghoshal UC, et al. Eur J Gastroenterol Hepatol. 2014 Jul;26(7):753-60. doi: 10.1097/MEG.0000000000000122. Eur J Gastroenterol Hepatol. 2014. PMID: 24849768 Clinical Trial.
-
Ghoshal UC, Nehra A, Mathur A, Rai S. Ghoshal UC, et al. J Gastroenterol Hepatol. 2020 Jun;35(6):922-931. doi: 10.1111/jgh.14938. Epub 2019 Dec 17. J Gastroenterol Hepatol. 2020. PMID: 31750966
-
Liu ZJ, Wei H, Duan LP, Zhu SW, Zhang L, Wang K. Liu ZJ, et al. Zhonghua Yi Xue Za Zhi. 2016 Jun 28;96(24):1896-902. doi: 10.3760/cma.j.issn.0376-2491.2016.24.005. Zhonghua Yi Xue Za Zhi. 2016. PMID: 27373356 Chinese.
-
Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?
Aziz I, Törnblom H, Simrén M. Aziz I, et al. Curr Opin Gastroenterol. 2017 May;33(3):196-202. doi: 10.1097/MOG.0000000000000348. Curr Opin Gastroenterol. 2017. PMID: 28257307 Review.
-
Ghoshal UC, Srivastava D. Ghoshal UC, et al. World J Gastroenterol. 2014 Mar 14;20(10):2482-91. doi: 10.3748/wjg.v20.i10.2482. World J Gastroenterol. 2014. PMID: 24627585 Free PMC article. Review.
Cited by
-
Role of the duodenal microbiota in functional dyspepsia.
Brown G, Hoedt EC, Keely S, Shah A, Walker MM, Holtmann G, Talley NJ. Brown G, et al. Neurogastroenterol Motil. 2022 Nov;34(11):e14372. doi: 10.1111/nmo.14372. Epub 2022 Apr 11. Neurogastroenterol Motil. 2022. PMID: 35403776 Free PMC article. Review.
-
Jo IH, Paik CN, Kim YJ, Lee JM, Choi SY, Hong KP. Jo IH, et al. J Neurogastroenterol Motil. 2023 Jan 30;29(1):85-93. doi: 10.5056/jnm22023. J Neurogastroenterol Motil. 2023. PMID: 36606439 Free PMC article.
-
Savarino E, Zingone F, Barberio B, Marasco G, Akyuz F, Akpinar H, Barboi O, Bodini G, Bor S, Chiarioni G, Cristian G, Corsetti M, Di Sabatino A, Dimitriu AM, Drug V, Dumitrascu DL, Ford AC, Hauser G, Nakov R, Patel N, Pohl D, Sfarti C, Serra J, Simrén M, Suciu A, Tack J, Toruner M, Walters J, Cremon C, Barbara G. Savarino E, et al. United European Gastroenterol J. 2022 Jul;10(6):556-584. doi: 10.1002/ueg2.12259. Epub 2022 Jun 13. United European Gastroenterol J. 2022. PMID: 35695704 Free PMC article. Review.
-
Wielgosz-Grochowska JP, Domanski N, Drywień ME. Wielgosz-Grochowska JP, et al. Nutrients. 2022 Aug 17;14(16):3382. doi: 10.3390/nu14163382. Nutrients. 2022. PMID: 36014888 Free PMC article. Review.
-
The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or Virome.
Yu Y, Wang W, Zhang F. Yu Y, et al. Adv Sci (Weinh). 2023 Dec;10(35):e2301097. doi: 10.1002/advs.202301097. Epub 2023 Nov 1. Adv Sci (Weinh). 2023. PMID: 37914662 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources